Retinoid-related orphan receptors (RORs): Roles in cell survival, differentation and disease

Cell Death and Differentiation

Volumn 9, Issue 11, 2002, Pages 1167-1171

  Jetten, A M ^a   Euda, E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CD4 ANTIGEN; CD8 ANTIGEN; CELL NUCLEUS RECEPTOR; CYCLIN DEPENDENT KINASE 2; CYCLOOXYGENASE 2; FAS ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MYOCYTE ENHANCER FACTOR 2; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; RETINOID RELATED ORPHAN RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BCL2L1 PROTEIN, MOUSE; CELL RECEPTOR; CELL SURFACE RECEPTOR; ORPHAN NUCLEAR RECEPTOR ROR GAMMA; ORPHAN NUCLEAR RECEPTOR ROR-GAMMA; PROTEIN BCL X; RAR RELATED ORPHAN RECEPTOR A; RAR-RELATED ORPHAN RECEPTOR A; RETINOIC ACID RECEPTOR; RETINOIC ACID RELATED ORPHAN RECEPTOR BETA; RETINOIC ACID-RELATED ORPHAN RECEPTOR BETA; THYROID HORMONE RECEPTOR; TRANSACTIVATOR PROTEIN;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MALFORMATION; CELL DIFFERENTIATION; CELL SURVIVAL; CEREBELLUM DEGENERATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISEASE COURSE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; THYMUS LYMPHOMA; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; GENETIC TRANSCRIPTION; GENETICS; PHYSIOLOGY; X RAY CRYSTALLOGRAPHY;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CRYSTALLOGRAPHY, X-RAY; GENE EXPRESSION REGULATION; MICE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 1842847181     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401085     Document Type: Article

References (44)

1. Jetten AM et al. (2001) Prog. Nucl. Acid Res. 69: 205-247
2. Giguere V et al. (1994) Genes Dev. 8: 538-553
3. Yan ZH et al. (1997) J. Biol. Chem. 272: 10565-10572
4. Glass CK and Rosenfeld MG (2000) Genes Dev. 14: 121-141
5. McKenna NJ et al. (1999) J. Steroid Biochem. Mol. Biol. 69: 3-12
6. Kane CD and Means AR (2000) EMBO J. 19: 691-701
7. McKinsey TA et al. (2002) Trends Biochem. Sci. 27: 40-47
8. Dussault I et al. (1998) Mech. Dev. 70: 147-153
9. Hamilton BA et al. (1996) Nature 379: 736-739
10. Steinmayr M et al. (1998) Proc. Natl. Acad. Sci. USA 95: 3960-3965
11. Xiao Q and Nikodem VM (1998) Front Biosci. 3: A52-A57
12. Meyer T et al. (2000) Proc. Natl. Acad. Sci. USA 97: 9197-9202
13. Kopmels B et al. (1992) J. Neurochem. 58: 192-199
14. Mamontova A et al. (1998) Circulation 98: 2738-2743
15. Delerive P et al. (2001) EMBO Rep. 2: 42-48
16. Andre E et al. (1998) EMBO J. 17: 3867-3877
17. Schaeren-Wiemers N et al. (1997) Eur. J. Neurosci. 9: 2687-2701
18. Kurebayashi S et al. (2000) Proc. Natl. Acad. Sci. USA 97: 10132-10137
19. Sun Z et al. (2000) Science 288: 2369-2373
20. Sebzda E et al. (1999) Annu. Rev. Immunol. 17: 829-874
21. Fehling HJ and von Boehmer H (1997) Curr. Opin. Immun. 9: 263-275
22. Ellmeier W et al. (1999) Annu. Rev. Immunol. 17: 523-554
23. Killeen N et al. (1998) Curr. Opin. Immunol. 10: 360-367
24. Zhang J et al. (2000) J. Immunol. 165: 2970-2974
25. Bouillet P et al. (2002) Nature 415: 922-926
26. Miyazaki T (1997) J. Exp. Med. 186: 877-885
27. Guo J et al. (2002) Nat. Immunol. 3: 469-476
28. Ma A et al. (1995) Proc. Natl. Acad. Sci. USA 92: 4763-4767
29. He YW et al. (1998). Immunity 9: 797-806
30. Hettmann T et al. (1999) J. Exp. Med. 189: 145-158
31. Chen C et al. (2000) Mol. Cell. Biol. 20: 2687-2695
32. Hakem A et al. (1999) J. Exp. Med. 189: 957-968
33. Distelhorst CW (2002) Cell Death Differ. 9: 6-19
34. Gil-Gomez G et al. (1998) EMBO J. 17: 7209-7218
35. Hiromura K et al. (2002) Oncogene 21: 1750-1758
36. Zou H et al. (1999) J. Biol. Chem. 274: 11549-11556
37. Vander Heiden MG et al. (1997) Cell 91: 627-637
38. Zamzami N and Kroemer G (2001) Nat. Rev. Mol. Cell. Biol. 2: 67-71
39. Zimmermann KC et al. (2001) Pharmacol. Ther. 92: 57-70
40. De Giorgi F et al. (2002) FASEB J. 25: in press
41. Ott M et al. (2002) Proc. Natl. Acad. Sci. USA 99: 1259-1263
42. Ueda E et al. (2002) Cancer Res. 62: 901-909
43. Stehlin C et al. (2001) EMBO J. 20: 5822-5831
44. Harris JM et al. (2002) Mol. Endocrinol. 16: 998-1012